Get the Stockscreener App
6.72
1.05%
0.07
Profound Medical Corp stock is traded at $6.72, with a volume of 22,523.
It is up +1.05% in the last 24 hours and down -2.75% over the past month.
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of AI-powered, MRI-guided, incision-free therapies for the ablation of diseased tissue. The company's flagship product, the TULSA-PRO system, combines real-time MRI, robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to ablate whole gland or physician defined region of malignant or benign prostate tissue. Its platform technologies combine imaging, robotic control, and ultrasound-based thermal ablation for the treatment of prostate conditions. The company generates revenue through the sale of capital equipment and recurring sales of single-use devices and related services used in patient treatments.
See More
Previous Close:
$6.65
Open:
$6.75
24h Volume:
22,523
Relative Volume:
0.25
Market Cap:
$245.50M
Revenue:
$18.81M
Net Income/Loss:
$-38.90M
P/E Ratio:
-5.3863
EPS:
-1.2476
Net Cash Flow:
$-38.83M
1W Performance:
+1.36%
1M Performance:
-2.75%
6M Performance:
-3.45%
1Y Performance:
+46.09%
1-Day Range:
$6.5249
$6.75
1-Week Range:
$6.51
$7.30
52-Week Range:
$3.76
$8.95
Profound Medical Corp Stock (PROF) Company Profile
Name
Profound Medical Corp
Sector
Industry
Phone
647-476-1350
Address
2400 SKYMARK AVENUE, UNIT 6, MISSISSAUGA, ON
Compare PROF vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PROF
Profound Medical Corp
|
6.72 | 258.65M | 18.81M | -38.90M | -38.83M | -1.2476 |
ABT
Abbott Laboratories
|
115.73 | 198.01B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
329.36 | 130.41B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
92.61 | 120.48B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
49.87 | 75.37B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
89.91 | 53.19B | 6.30B | 1.07B | 1.09B | 1.8406 |
Profound Medical Corp Stock (PROF) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-23-24 | Initiated | Lake Street | Buy |
| Jul-16-24 | Upgrade | Stifel | Hold → Buy |
| Nov-28-23 | Initiated | Stifel | Hold |
| Aug-04-23 | Downgrade | Raymond James | Strong Buy → Outperform |
| Mar-21-23 | Downgrade | Jefferies | Buy → Hold |
| Sep-15-20 | Initiated | Jefferies | Buy |
View All
Profound Medical Corp Stock (PROF) Latest News
Profound (PROF) Earnings Report: The Bottom-Line Figure Outpaces Its Comparison in the Latest Session; Investor Response: The Stock Ends Down 6.07% in the Available RecordRevenue Warning Signal - Vinanet
Profound Medical (PROF) Q2 2026 Earnings Call Transcript - AOL.ca
Why Did Profound Medical Corp. (TSX:PRN) Surge 6.09% on 18 August 2026? - kalkine.ca
Why Profound Medical Corp stock surged yesterday - Wealth Awesome
Profound Medical Stock: Record Orders Meet a CFO Shake-Up - kalkine.ca
Profound Medical (TSX:PRN) Captures Focus Amid Developing Healthcare Story - Kalkine Media
Why Profound Medical Corp stock is skyrocketing today - Wealth Awesome
Profound Medical (TSX:PRN): Could The Market Be Seeing More Potential Ahead? - Kalkine Media
Profound Medical (TSE:PRN) Insider Thomas Michael Tamberrino Buys 3,755 Shares of Stock - MarketBeat
symbol__ Stock Quote Price and Forecast - CNN
Profound Medical Launches TULSA-PRO Software Upgrade Targeting Up to Six Procedures Per Day - Minichart
Profound Medical Launches Enhanced TULSA-PRO Software Upgrade - TipRanks
Form 8K PROFOUND MEDICAL CORP. For: 17 August By Investing.com - Investing.com Nigeria
Profound Medical Names Interim CFO Amid Leadership Transition - TipRanks
Profound Medical (NASDAQ: PROF) targets higher TULSA throughput - Stock Titan
Profound’s Introduction of New Real-time Interventional MRI Software Paving the Way for Full ‘TULSA Days’ - marketscreener.com
Some physicians report four TULSA procedures a day—what changes next? - Stock Titan
Profound Medical (PROF) shifts CFO, ex-finance chief stays on as paid adviser - Stock Titan
Profound Medical Announces Management Change - The Manila Times
Profound Medical Corp. Announces CFO Changes - marketscreener.com
Profound Medical Corp. Share Price Live Today – NASDAQ:PROF Stock Price, Chart, News, History - Upstox
Profound Medical Unveils 'Let's Huddle' Patient Advocacy Program in August 2026 Filing - Kalkine Media
Profound Medical Launches Global Prostate Patient Advocacy Community - TipRanks
Profound Medical (PROF) launches global ‘Let’s Huddle’ prostate patient community - Stock Titan
Profound Medical Launches ‘Let's Huddle’, a Global Community Supporting Men Throughout Their Prostate Care Journey - The Manila Times
A prostate cancer survivor helps men navigate care through Let's Huddle - Stock Titan
Understanding Momentum Shifts in (PROF) - Stock Traders Daily
Profound Medical Stock Slides 4.5% on August 11 — Is the Latest Weakness Creating a Contrarian Entry? - kalkine.ca
Why Profound Medical Corp stock is sliding today - Wealth Awesome
Profound Medical (PROF) Drops 3.5% to $7.15 as Key Support Comes into ViewTotal Put Call - dars.gov.et
Why Profound Medical Corp stock plummeted yesterday - Wealth Awesome
Profound Medical Corp (TSX:PRN) Shares Under Pressure as Investor Confidence Weakens and Healthcare Volatility Rises - kalkine.ca
Profound Medical (TSX:PRN) Just Booked Record Orders — So Why Did Revenue Look Soft? - kalkine.ca
Q2 2026 Profound Medical Corp Earnings Call Transcript - GuruFocus
Profound Medical Corp. Q2 2026 Earnings Call Summary - Yahoo Finance
Profound Medical Q2 Earnings Call Highlights - Yahoo Finance
Profound Medical Corp (PROF) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Profound Medical Corp (PROF) (Q2 2026) Earnings Call Highlights: - GuruFocus
Profound Medical (NASDAQ:PROF) Announces Earnings Results - MarketBeat
Profound Medical Corp reports results for the quarter ended June 30Earnings Summary - TradingView
Profound Medical (PROF) Q2 Earnings Surpass Estimates - Yahoo Finance
Earnings call transcript: Profound Medical Q2 2026 revenue rises, stock slips 3.5% - Investing.com
Profound Medical Reports Second Quarter 2026 Financial Results - The Manila Times
Profound Medical Corp. 2026: Revenue $2.48M, EPS ($0.26) — 10-Q Summary - TradingView
Profound Medical (NASDAQ: PROF) boosts revenue 62% while cutting loss - Stock Titan
PROFOUND MEDICAL CORP (PRN.TO) Q2 FY2026 earnings call transcript - Yahoo Finance
About $3.1M of Profound shipments will count as Q3 revenue - Stock Titan
Profound Medical (NASDAQ: PROF) Q2 loss narrows as revenue rises - Stock Titan
Profound Medical Corp. Reiterates Earnings Guidance for the Full Year 2026 - marketscreener.com
PROF Q2 FY2026 earnings call - finance.biggo.com
Earnings To Watch: Profound Medical Corp (PROF) Q2 2026 -- GF Value Sees 226% Upside - Yahoo Finance
Profound Medical Corp Stock (PROF) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.32%
0.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):